Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Insys Therapeutics, Inc. | 42,447,810 | reported | 27 Feb 2018 | tx 27+144,691−42,579,689 |
| NEOPHARM INC | 5,377,826 | reported | 13 Mar 2009 | tx 31+889,888−405 |
| FIRST HORIZON PHARMACEUTICAL CORP | 2,406,374 | reported | 11 Dec 2006 | tx 6+358,583−5,050,000 |
| AKORN INC | 513,479 | reported | 04 May 2017 | tx 82+75,396,292−45,239,293 |
| INTROGEN THERAPEUTICS INC | 125,000 | reported | 12 Jun 2008 | tx 8+243,338 |
| OPTION CARE INC/DE | 15,000 | reported | 04 May 2007 | tx 2+15,000−4,263,878 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2018 | OTHER | Insys Therapeutics, Inc. | 31,982 | 0.00 USD | |
| 27 Feb 2018 | OTHER | Insys Therapeutics, Inc. | 42,447,810 | 0.00 USD | |
| 27 Feb 2018 | OTHER | Insys Therapeutics, Inc. | 56,288 | 0.00 USD | |
| 04 May 2017 | GRANT_AWARD | AKORN INC | 8,088 | 0.00 USD | |
| 21 Feb 2017 | GRANT_AWARD | Insys Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 21 Feb 2017 | GRANT_AWARD | Insys Therapeutics, Inc. | 4,000 | 0.00 USD | deriv |
| 12 Aug 2016 | PURCHASE | Insys Therapeutics, Inc. | 5,700 | 18.57 USD | |
| 01 Jul 2016 | GRANT_AWARD | AKORN INC | 4,661 | 0.00 USD | |
| 01 Jul 2016 | GRANT_AWARD | AKORN INC | 11,602 | 0.00 USD | deriv |
| 12 May 2016 | PURCHASE | Insys Therapeutics, Inc. | 10,000 | 12.41 USD | |
| 11 May 2016 | PURCHASE | Insys Therapeutics, Inc. | 40,000 | 12.94 USD | |
| 11 Dec 2015 | GIFT | AKORN INC | 15,050,000 | 0.00 USD | |
| 11 Dec 2015 | GIFT | AKORN INC | 15,050,000 | 0.00 USD | |
| 11 Nov 2015 | PURCHASE | Insys Therapeutics, Inc. | 900 | 26.15 USD | |
| 11 Nov 2015 | PURCHASE | Insys Therapeutics, Inc. | 9,100 | 25.46 USD | |
| 05 May 2015 | GRANT_AWARD | Insys Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 10 Mar 2015 | PURCHASE | AKORN INC | 19,000 | 44.26 USD | |
| 11 Dec 2014 | SALE | AKORN INC | 32,300 | 41.17 USD | |
| 10 Dec 2014 | SALE | AKORN INC | 17,700 | 41.22 USD | |
| 26 Aug 2014 | SALE | AKORN INC | 50,000 | 38.99 USD | |
| 07 Aug 2014 | GRANT_AWARD | Insys Therapeutics, Inc. | 9,000 | 0.00 USD | deriv |
| 16 Jun 2014 | PURCHASE | Insys Therapeutics, Inc. | 2,000 | 26.53 USD | first after silence |
| 16 Jun 2014 | PURCHASE | Insys Therapeutics, Inc. | 3,000 | 25.85 USD | |
| 19 May 2014 | EXERCISE | Insys Therapeutics, Inc. | 1,843 | 17.08 USD | |
| 19 May 2014 | EXERCISE | Insys Therapeutics, Inc. | 2,304 | 11.79 USD |
3 purchases reported after at least 12 months of silence — most recent on 16 Jun 2014.